bay y3118 has been researched along with ampicillin in 2 studies
| Studies (bay y3118) | Trials (bay y3118) | Recent Studies (post-2010) (bay y3118) | Studies (ampicillin) | Trials (ampicillin) | Recent Studies (post-2010) (ampicillin) |
|---|---|---|---|---|---|
| 37 | 0 | 0 | 14,685 | 1,251 | 2,266 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, J; Budeanu, C; Hof, H; Kretschmar, M; Linss, W; Nichterlein, T | 1 |
| Hof, H; Nichterlein, T; Walz, A | 1 |
2 other study(ies) available for bay y3118 and ampicillin
| Article | Year |
|---|---|
Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells.
Topics: Ampicillin; Animals; Anti-Infective Agents; Cell Line; Chronic Disease; Female; Fluoroquinolones; Interferon-gamma; Interleukin-6; Listeria monocytogenes; Listeriosis; Liver; Mice; Mice, Nude; Microbial Sensitivity Tests; Microscopy, Electron; Quinolones; Spleen | 1994 |
Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Fluoroquinolones; Gentamicins; Legionella pneumophila; Legionnaires' Disease; Macrophages; Mice; Penicillins; Quinolones; Tumor Cells, Cultured | 1997 |